Weekly Dose: flibanserin, the drug that gives women one extra sexually satisfying experience every two months
- Written by Jayne Lucke, Professor & Director of the Australian Research Centre in Sex, Health & Society, La Trobe University
The United States Food and Drug Administration (FDA) approved the drug flibanserin (sold under the brand name Addyi) for the treatment of women with hypo-active sexual desire disorder (HSDD) in August 2015.
Australia hasn’t followed suit, though flibanserin is available through internet pharmacies. However, its limited effectiveness and serious side-effects should cause potential users to rethink purchasing flibanserin online.
Authors: Jayne Lucke, Professor & Director of the Australian Research Centre in Sex, Health & Society, La Trobe University